Literature DB >> 3244381

Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

T Halbrügge1, A L Ungell, R Wölfel, K H Graefe.   

Abstract

1. Rabbits were anaesthetized with urethane/chloralose and infused intravenously with trace amounts of 3H-2,5,6-, 3H-7,8- or 3H-7-(-)noradrenaline either without or with unlabelled (-)noradrenaline being simultaneously infused (0.2 micrograms kg-1 min-1). To obtain clearance values and extraction ratios for the pulmonary, systemic and total circulation, steady-state concentrations of infused noradrenaline were determined in mixed central venous (Cv) and arterial (Ca) plasma. Heart rate and blood pressure were recorded via the carotid artery, and the dye dilution method was used to determine the cardiac output of plasma. 2. The simultaneous infusion of unlabelled noradrenaline, which increased plasma levels of noradrenaline by a factor of 5, had no significant effect on either heart rate, blood pressure or cardiac output (when determined at steady state of the noradrenaline infusion). 3. The simultaneous infusion of unlabelled noradrenaline did not affect the clearance values of any of the three type of 3H-noradrenaline. Moreover, the clearances of the various types of 3H-noradrenaline were virtually identical and agreed with that of unlabelled noradrenaline. However, the clearance of labelled and unlabelled noradrenaline from arterial plasma was 1.15 times higher than that from central venous plasma. This factor corresponded to the ratio of Cv/Ca and pointed towards net removal of noradrenaline from the pulmonary circulation. 4. The fractional pulmonary extractions [1-(Ca/Cv)] of the three types of 3H-noradrenaline did not differ from each other and were not affected by the simultaneous infusion of unlabelled noradrenaline.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244381     DOI: 10.1007/BF00172110

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

Review 1.  Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.

Authors:  M Esler; G Jennings; P Korner; I Willett; F Dudley; G Hasking; W Anderson; G Lambert
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

2.  Norepinephrine: hormone and neurotransmitter in man.

Authors:  A B Silverberg; S D Shah; M W Haymond; P E Cryer
Journal:  Am J Physiol       Date:  1978-03

3.  Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stress.

Authors:  J Hilsted; N J Christensen; S Madsbad
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

4.  The isotope effect of tritium in 3H-noradrenaline.

Authors:  U Trendelenburg; F J Stefano; M Grohmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

5.  Pulmonary extraction of circulating noradrenaline in man.

Authors:  J H Henriksen; N J Christensen; H Ring-Larsen
Journal:  Eur J Clin Invest       Date:  1986-10       Impact factor: 4.686

6.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

7.  The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

8.  Plasma concentrations of noradrenaline and 3,4-dihydroxyphenylethyleneglycol under conditions of enhanced sympathetic activity.

Authors:  J Ludwig; T Gerhardt; T Halbrügge; J Walter; K H Graefe
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Modulation of noradrenaline release in the conscious rabbit through alpha-adrenoceptors.

Authors:  H Majewski; L Hedler; K Starke
Journal:  Eur J Pharmacol       Date:  1983-09-30       Impact factor: 4.432

10.  Estimation of intrasynaptic norepinephrine concentrations in humans.

Authors:  D S Goldstein; R Zimlichman; R Stull; H R Keiser; I J Kopin
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

View more
  14 in total

1.  The part played by catechol-O-methyltransferase in the plasma kinetics of 3,4-dihydroxyphenylglycol and 3,4-dihydroxyphenylalanine in the anaesthetized rabbit.

Authors:  B Friedgen; T Halbrügge; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

2.  Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.

Authors:  T Halbrügge; B Friedgen; J Ludwig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

3.  Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover.

Authors:  A Aneman; G Eisenhofer; L Olbe; J Dalenbäck; P Nitescu; L Fändriks; P Friberg
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

4.  The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines.

Authors:  B Friedgen; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  Plasma 3,4-dihydroxyphenylglycol as a tool to assess the role of neuronal uptake in the anaesthetized rabbit.

Authors:  T Halbrügge; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

6.  Desipramine inhibits sympathetic nerve activity in the rabbit.

Authors:  B Sazbo; A Schultheiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

7.  Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit.

Authors:  O S Medvedev; M D Esler; J A Angus; H S Cox; G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

8.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

9.  Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.

Authors:  B Szabo; T Auberle; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

10.  Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.

Authors:  G Eisenhofer; H S Cox; M D Esler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.